BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 27188453)

  • 21. Genotype and phenotype analysis of a cohort of patients with congenital hyperinsulinism based on DOPA-PET CT scanning.
    Ni J; Ge J; Zhang M; Hussain K; Guan Y; Cheng R; Xi L; Zheng Z; Ren S; Luo F
    Eur J Pediatr; 2019 Aug; 178(8):1161-1169. PubMed ID: 31218401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and genetic characteristics of patients with congenital hyperinsulinism in 21 non-consanguineous families from Serbia.
    Raicevic M; Milenkovic T; Hussain K; Djordjevic M; Martic J; Todorovic S; Mitrovic K; Sarajlija A; Vukovic R
    Eur J Pediatr; 2021 Sep; 180(9):2815-2821. PubMed ID: 33770274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up and mutation analysis of 27 chinese cases of congenital hyperinsulinism.
    Su C; Gong C; Sanger P; Li W; Wu D; Gu Y; Cao B
    Horm Res Paediatr; 2014; 81(3):169-76. PubMed ID: 24434300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel mutation c.597_598dup in exon 5 of ABCC8 gene causing congenital hyperinsulinism.
    Jindal R; Ahmad A; Siddiqui MA; Kochar IS; Wangnoo SK
    Diabetes Metab Syndr; 2014; 8(1):45-7. PubMed ID: 24661758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Congenital hyperinsulinism: clinical and molecular analysis of a large Italian cohort.
    Faletra F; Athanasakis E; Morgan A; Biarnés X; Fornasier F; Parini R; Furlan F; Boiani A; Maiorana A; Dionisi-Vici C; Giordano L; Burlina A; Ventura A; Gasparini P
    Gene; 2013 May; 521(1):160-5. PubMed ID: 23506826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update of variants identified in the pancreatic β-cell K
    De Franco E; Saint-Martin C; Brusgaard K; Knight Johnson AE; Aguilar-Bryan L; Bowman P; Arnoux JB; Larsen AR; Sanyoura M; Greeley SAW; Calzada-León R; Harman B; Houghton JAL; Nishimura-Meguro E; Laver TW; Ellard S; Del Gaudio D; Christesen HT; Bellanné-Chantelot C; Flanagan SE
    Hum Mutat; 2020 May; 41(5):884-905. PubMed ID: 32027066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Focal congenital hyperinsulinism managed by medical treatment: a diagnostic algorithm based on molecular genetic screening.
    Maiorana A; Barbetti F; Boiani A; Rufini V; Pizzoferro M; Francalanci P; Faletra F; Nichols CG; Grimaldi C; de Ville de Goyet J; Rahier J; Henquin JC; Dionisi-Vici C
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):679-88. PubMed ID: 24383515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Congenital Hyperinsulinism Caused by Mutations in
    Butnariu LI; Bizim DA; Păduraru G; Păduraru L; Moisă ȘM; Popa S; Gimiga N; Ghiga G; Bădescu MC; Lupu A; Vasiliu I; Trandafir LM
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperinsulinism in infancy--genetic aspects.
    Darendeliler F; Bas F
    Pediatr Endocrinol Rev; 2006 Aug; 3 Suppl 3():521-6. PubMed ID: 17551476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Congenital hyperinsulinism due to compound heterozygous mutations in ABCC8 responsive to diazoxide therapy.
    Taylor-Miller T; Houghton J; Munyard P; Kumar Y; Puvirajasinghe C; Giri D
    J Pediatr Endocrinol Metab; 2020 May; 33(5):671-674. PubMed ID: 32267248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KATP channel mutations in congenital hyperinsulinism.
    Saint-Martin C; Arnoux JB; de Lonlay P; Bellanné-Chantelot C
    Semin Pediatr Surg; 2011 Feb; 20(1):18-22. PubMed ID: 21185999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dominantly acting ABCC8 mutations in patients with medically unresponsive hyperinsulinaemic hypoglycaemia.
    Flanagan SE; Kapoor RR; Banerjee I; Hall C; Smith VV; Hussain K; Ellard S
    Clin Genet; 2011 Jun; 79(6):582-7. PubMed ID: 20573158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of two novel frameshift mutations in the KCNJ11 gene in two Italian patients affected by Congenital Hyperinsulinism of Infancy.
    Biagiotti L; Proverbio MC; Bosio L; Gervasi F; Rovida E; Cerioni V; Bove M; Valin PS; Albarello L; Zamproni I; Grassi S; Doglioni C; Mora S; Chiumello G; Biunno I
    Exp Mol Pathol; 2007 Aug; 83(1):59-64. PubMed ID: 17316607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and genetic evaluation of patients with KATP channel mutations from the German registry for congenital hyperinsulinism.
    Mohnike K; Wieland I; Barthlen W; Vogelgesang S; Empting S; Mohnike W; Meissner T; Zenker M
    Horm Res Paediatr; 2014; 81(3):156-68. PubMed ID: 24401662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics of recessive and dominant congenital hyperinsulinism due to mutation(s) in the ABCC8/KCNJ11 genes encoding the ATP-sensitive potasium channel in the pancreatic beta cell.
    Oçal G; Flanagan SE; Hacihamdioğlu B; Berberoğlu M; Siklar Z; Ellard S; Savas Erdeve S; Okulu E; Akin IM; Atasay B; Arsan S; Yağmurlu A
    J Pediatr Endocrinol Metab; 2011; 24(11-12):1019-23. PubMed ID: 22308858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanisms of congenital hyperinsulinism due to autosomal dominant mutations in ABCC8.
    Nessa A; Aziz QH; Thomas AM; Harmer SC; Tinker A; Hussain K
    Hum Mol Genet; 2015 Sep; 24(18):5142-53. PubMed ID: 26092864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations.
    Pinney SE; MacMullen C; Becker S; Lin YW; Hanna C; Thornton P; Ganguly A; Shyng SL; Stanley CA
    J Clin Invest; 2008 Aug; 118(8):2877-86. PubMed ID: 18596924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sirolimus in the treatment of three infants with diffuse congenital hyperinsulinism.
    Al-Balwi R; Al-Atawi M; Al-Otaibi A; Babiker O; Al-Mutair A
    J Pediatr Endocrinol Metab; 2017 Aug; 30(9):1013-1017. PubMed ID: 28787272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation spectra of ABCC8 gene in Spanish patients with Hyperinsulinism of Infancy (HI).
    Fernández-Marmiesse A; Salas A; Vega A; Fernández-Lorenzo JR; Barreiro J; Carracedo A
    Hum Mutat; 2006 Feb; 27(2):214. PubMed ID: 16429405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital hyperinsulinism due to a compound heterozygous ABCC8 mutation with spontaneous resolution at eight weeks.
    Kumaran A; Kapoor RR; Flanagan SE; Ellard S; Hussain K
    Horm Res Paediatr; 2010; 73(4):287-92. PubMed ID: 20215776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.